Ingrid Chen
Overview
Explore the profile of Ingrid Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen I, Doum D, McIver D, Keo V, Vong P, Pech S, et al.
Malar J
. 2025 Feb;
24(1):59.
PMID: 39987203
Background: Cambodia strives to eliminate all species of human malaria by 2025, requiring that foci among forest-exposed populations in remote settings be addressed. This study explores malaria risks amongst forest-exposed...
2.
Pitsava G, Hawley M, Auriga L, de Dios I, Ko A, Marmolejos S, et al.
medRxiv
. 2025 Jan;
PMID: 39763557
Introduction: Advancements in sequencing technologies have significantly improved clinical genetic testing, yet the diagnostic yield remains around 30-40%. Emerging sequencing technologies are now being deployed in the clinical setting to...
3.
Chen I, Doum D, McIver D, Keo V, Vong P, Pech S, et al.
Res Sq
. 2024 Nov;
PMID: 39574898
Background: Cambodia strives to eliminate all species of human malaria by 2025, requiring that foci among forest-exposed populations in remote settings be addressed. This study explores malaria risk factors amongst...
4.
Chotsiri P, Mahamar A, Diawara H, Fasinu P, Diarra K, Sanogo K, et al.
Malar J
. 2024 May;
23(1):159.
PMID: 38773528
Background: Primaquine (PQ) is the prototype 8-aminoquinoline drug, a class which targets gametocytes and hypnozoites. The World Health Organization (WHO) recommends adding a single low dose of primaquine to the...
5.
Jebiwott S, Gutapaka N, Sumari D, Loss G, Athuman T, Nyandele J, et al.
BMJ Open
. 2024 Mar;
14(3):e082227.
PMID: 38538037
Introduction: As malaria declines, low-density malaria infections (LMIs) represent an increasing proportion of infections and may have negative impacts on child health and cognition, necessitating development of targeted and effective...
6.
Newby G, Cotter C, Roh M, Harvard K, Bennett A, Hwang J, et al.
Malar J
. 2024 Mar;
23(1):63.
PMID: 38429746
No abstract available.
7.
Newby G, Cotter C, Roh M, Harvard K, Bennett A, Hwang J, et al.
Malar J
. 2023 Sep;
22(1):254.
PMID: 37661286
Background: Global interest in malaria elimination has prompted research on active test and treat (TaT) strategies. Methods: A systematic review and meta-analysis were conducted to assess the effectiveness of TaT...
8.
Chen I, Doum D, Mannion K, Hustedt J, Sovannaroth S, McIver D, et al.
Malar J
. 2023 Sep;
22(1):251.
PMID: 37658337
Background: Southeast Asia is making tremendous progress towards their 2030 malaria elimination goal but needs new interventions to stop forest malaria. This study trials two new vector control tools, a...
9.
Zhao J, Reuther J, Scozzaro K, Hawley M, Metzger E, Emery M, et al.
Mol Diagn Ther
. 2023 Aug;
27(6):753-768.
PMID: 37632661
Background: Highly sensitive molecular assays have been developed to detect plasma-based circulating tumor DNA (ctDNA), and emerging evidence suggests their clinical utility for monitoring minimal residual disease and recurrent disease,...
10.
Chen I, Ishengoma D
Lancet Infect Dis
. 2023 Jun;
23(9):990-992.
PMID: 37327810
No abstract available.